Progress
A tender has been published for Hospital Medical Education Hematology Analyzer (Fully-Automated) (Q2) in AIZAWL, MIZORAM. Quantity: 2 by. Submission Deadline: 04-09-2026 12: 00: 00. Check eligibility and apply.
Quantity
2
Bid Type
Single Packet Bid
Bid Validity
30 (Days)
Bid Type
Service
Evaluation
Total value wise evaluation
Inspection Required
No
Tech Clarification Time
2 Days
EMD Required
No
MII Purchase Preference
No
MSE Purchase Preference
No
MSE Exemption/Relaxation
No
Startup Exemption/Relaxation
No
Bid Splitting Applied
No
Min. Avg. Annual Turnover
3
OEM Avg. Turnover
10
Past Performance
30 %
Warranty Period
2 years
Experience Required
2 Year (s)
Arbitration Clause
No
Mediation Clause
No
Tender Category
Goods
Bid To RA
No
Bid To RA Enabled
No
Item Category
Hematology Analyzer (Fully-Automated) (Q2)
Advisory Bank
State Bank of India
ePBG Percentage
5%
ePBG Duration (Months)
16
Payment Timelines
Payments shall be made to the Seller within 45 days of issue of consignee receipt-cum-acceptance certificate (CRAC) and on-line submission of bills (This is in supersession of 10 days time as provided in clause 12 of GeM GTC)
Max Delivery Days
45
Delivery Locations
1
Delivery Cities
Aizawl
Delivery Pincodes
796001
| Consignee | Address | City | State | Pincode | Quantity | Delivery Days | Additional Requirement |
|---|---|---|---|---|---|---|---|
| C.Zothansangi | 796001,Mizoram New Capital Complex (MINECO), Khatla, Aizawl | Aizawl | Mizoram | 796001 | 2 | 45 | - |
End-to-end support — bid preparation, GeM registration, document filing & compliance by industry experts.
Free consultation · 24h response
Main Document
CATALOG Specification
ATC
GEM_GENERAL_TERMS_AND_CONDITIONS
Extended Deadline
04-Sep-2026, 6:30 am
Opening Date
04-Sep-2026, 7:00 am
Discover companies most likely to bid on this tender
Experience Criteria
Past Performance
Bidder Turnover
Certificate (Requested in ATC)
OEM Authorization Certificate
OEM Annual Turnover
Additional Doc 1 (Requested in ATC)
Compliance of BoQ specification and supporting document *In case any bidder is seeking exemption from Experience / Turnover Criteria
the supporting documents to prove his eligibility for exemption must be uploaded for evaluation by the buyer
| Category | Specification | Requirement |
|---|---|---|
| ANALYSIS PARAMETERS | Type | 3-Part |
| ANALYSIS PARAMETERS | WBC Differential (Reportable) | 3-Part (Lymphocytes, Mid-Cells/Mixed Cells, Granulocytes/Neutrophils) |
| ANALYSIS PARAMETERS | Core CBC Parameters (Reportable) | WBC, RBC, HGB, HCT, MCV, MCH, MCHC, RDW-SD, RDW-CV, PLT, MPV Or higher |
| ANALYSIS PARAMETERS | Reticulocyte Count | No |
| ANALYSIS PARAMETERS | NRBC (Nucleated Red Blood Cells) | No |
| ANALYSIS PARAMETERS | Immature Platelet Fraction (IPF) | No |
| ANALYSIS PARAMETERS | Body Fluid (Reportable) | No |
| ANALYSIS PARAMETERS | Minimum Throughput (Samples/hour) | 50.0 Or higher |
| SAMPLE | Modes available for sample running | Open Tube, Capillary/Pre-diluted |
| SAMPLE | Sample Loading Mode | Manual Loading |
| SAMPLE | STAT Capability | No |
| CALIBRATION & QUALITY CONTRAOL | Calibration Type | Automatic and Manual Both Or higher |
| CALIBRATION & QUALITY CONTRAOL | Quality Control Type | Automatic and Manual Both Or higher |
| CALIBRATION & QUALITY CONTRAOL | QC Levels (Minimum) | 2 Levels Or higher |
| CALIBRATION & QUALITY CONTRAOL | QC Trend Analysis | Levey-Jennings Charts / Westgard Rules |
| DISPLAY & INTERFACE | Inbuilt Screen Size | ≥ 5 inch |
| DISPLAY & INTERFACE | Printer Type | External Printer Compatible |
| DISPLAY & INTERFACE | Connectivity | USB, LAN, LIS/HIS Integration |
| DISPLAY & INTERFACE | Data Storage Capacity (Number of results storable) | ≥ 50000 Or higher |
| DISPLAY & INTERFACE | Barcode Reader | Yes |
| OTHER FEATURES | Features | Abnormality Flagging Capability, Clogging detection, overflow protection, Reagent level monitor, Error Detection & Alerts, Automatic Cleaning Cycles, System self-check on startup |
| CERTIFICATIONS | Availability of valid medical device license (CDSCO License) for the product issued from the competent authority defined under Drugs and Cosmetic Act 1940 and Rules as amended till date | Yes |